XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Revenues $ 41,734 $ 15,662 $ 78,842 $ 63,300
Costs and expenses:        
Cost of product sales 3,007 1,665 3,235 1,704
Cost of manufacturing services 136 0 2,358 0
Research and development 48,191 49,823 161,373 158,724
Selling, general and administrative 15,355 17,161 45,277 47,431
Total costs and expenses 66,689 68,649 212,243 207,859
Loss from operations (24,955) (52,987) (133,401) (144,559)
Other income 142 101 841 466
Net loss (24,813) (52,886) (132,560) (144,093)
Other comprehensive loss:        
Unrealized gain (loss) on investments 213 (4) (52) 4
Comprehensive loss $ (24,600) $ (52,890) $ (132,612) $ (144,089)
Basic net loss per common share (in usd per share) $ (0.40) $ (0.86) $ (2.16) $ (2.42)
Diluted net loss per common share (in usd per share) $ (0.40) $ (0.86) $ (2.16) $ (2.42)
Basic weighted average common shares outstanding (in shares) 61,459,831 61,169,754 61,390,143 59,494,836
Diluted weighted average common shares outstanding (in shares) 61,459,831 61,169,754 61,390,143 59,494,836
Collaborative and other agreements        
Revenues:        
Revenues $ 35,674 $ 11,986 $ 59,630 $ 54,338
Product sales, net        
Revenues:        
Revenues 4,371 3,591 12,623 7,681
Government agreements        
Revenues:        
Revenues 547 85 1,455 1,281
Contract Manufacturing        
Revenues:        
Revenues $ 1,142 $ 0 $ 5,134 $ 0